Nuveen
SNY icon

Nuveen’s Sanofi SNY Stock Holding History

Nuveen’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.8M Sell
416,308
-1,494,918
-78% -$66.8M ﹤0.01% 1347
2026
Q1 		$92.1M Buy
1,911,226
+370,227
+24% +$17.3M 0.02% 417
2025
Q4 		$74.7M Sell
1,540,999
-1,539,745
-50% -$76.3M 0.02% 488
2025
Q3 		$145M Sell
3,080,744
-16,170
-0.5% -$780K 0.04% 318
2025
Q2 		$150M Sell
3,096,914
-109,552
-3% -$5.6M 0.04% 307
2025
Q1 		$178M Sell
3,206,466
-469,758
-13% -$25.4M 0.05% 284
2024
Q4 		$177M Buy
3,676,224
+34,660
+1% +$1.76M 0.05% 280
2024
Q3 		$210M Buy
3,641,564
+390,088
+12% +$21.1M 0.06% 253
2024
Q2 		$158M Buy
3,251,476
+676,264
+26% +$32.6M 0.05% 302
2024
Q1 		$125M Sell
2,575,212
-1,928,745
-43% -$94.2M 0.04% 363
2023
Q4 		$224M Buy
4,503,957
+305,781
+7% +$15M 0.07% 222
2023
Q3 		$225M Buy
4,198,176
+1,232,468
+42% +$65.7M 0.08% 206
2023
Q2 		$160M Sell
2,965,708
-93,238
-3% -$5.02M 0.06% 280
2023
Q1 		$166M Buy
3,058,946
+987,166
+48% +$48M 0.06% 262
2022
Q4 		$100M Buy
+2,071,780
New +$90.9M 0.04% 368
2022
Q1 		– Sell
-273,334
Closed -$13.7M – 3420
2021
Q4 		$13.7M Sell
273,334
-21,104
-7% -$1.04M ﹤0.01% 1491
2021
Q3 		$14.2M Sell
294,438
-2,129
-0.7% -$108K ﹤0.01% 1523
2021
Q2 		$15.6M Sell
296,567
-511
-0.2% -$26.7K ﹤0.01% 1562
2021
Q1 		$14.7M Sell
297,078
-15,175
-5% -$729K ﹤0.01% 1547
2020
Q4 		$15.2M Buy
312,253
+212,949
+214% +$10.5M 0.01% 1425
2020
Q3 		$4.98M Sell
99,304
-74
-0.1% -$3.81K ﹤0.01% 1915
2020
Q2 		$5.07M Sell
99,378
-166,591
-63% -$8.1M ﹤0.01% 1890
2020
Q1 		$11.6M Sell
265,969
-354,614
-57% -$17M 0.01% 1204
2019
Q4 		$31.2M Sell
620,583
-49,707
-7% -$2.33M 0.01% 922
2019
Q3 		$31.1M Sell
670,290
-788
-0.1% -$34K 0.01% 901
2019
Q2 		$29M Buy
+671,078
New +$28.5M 0.01% 954
2013
Q3 		– Sell
-33,466
Closed -$1.72M – 1560
2013
Q2 		$1.72M Buy
+33,466
New +$1.78M 0.01% 812

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Nuveen's SNY Position: Q2 2026 in Review

Nuveen reduced its Sanofi (SNY) stake by 78% in Q2 2026, selling an estimated $66.8M and leaving 416,308 shares worth $17.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1347.

Nuveen first reported a position in SNY in Q2 2013 and has held it in 27 quarters since. The position peaked at $225M in Q3 2023. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Nuveen held 416,308 shares of Sanofi worth $17.8M as of Q2 2026.
  • Nuveen sold 1,494,918 Sanofi shares in Q2 2026, an estimated $66.8M.
  • Sanofi made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #1347 holding.
  • Nuveen first reported a position in Sanofi in Q2 2013 and has held it in 27 quarters since.
  • Nuveen's Sanofi position peaked at $225M in Q3 2023.
  • 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.